High-dose versus standard-dose radiotherapy in concurrent chemoradiotherapy for inoperable esophageal cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

High-dose versus standard-dose radiotherapy in concurrent chemoradiotherapy for inoperable esophageal cancer: A systematic review and meta-analysis

Published:2023-07 Issue: Volume:184 Page:109700
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Yao Yuanhu,Lu Jiaying,Qin Zhaohui,Li Na,Ma Ji,Yao Nan,Qu Wanxi,Cui Li,Yuan Shiwang,Jiang Aijun,Liu Xiaoxiao^ORCID

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference20 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Ca-Cancer J Clin,2021

2. Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends;van Rossum;Nat Rev Gastroenterol Hepatol,2018

3. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study;Zeng;Lancet Public Health,2021

4. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01);Cooper;Radiat Therapy Oncol Group Jama,1999

5. A Phase III multicenter randomized clinical trial of 60 Gy versus 50 Gy radiation dose in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma;Xu;Clin Cancer Res,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023;Clinical Oncology;2024-09

2. Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial;Cancer Communications;2024-08-19

3. Enhancing Prediction for Tumor Pathologic Response to Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Cancer by Dynamic Parameters from Clinical Assessments;Cancers;2023-09-01